Who We Are
We are committed to exploring distinct unrevealed health benefits inherent in 5000 years old Medical Science AYURVEDA, literally meaning the knowledge of health and meaningful quality life. AIMIL believes that research is the key to unearthing nature's secrets.
We are one of the fastest growing Ayurvedic Pharmaceutical company, which emerges as one of the first 100 Pharmaceutical Organizations (including all pharmaceutical giants & MNC's) in its field as per recent data statistic of ORG-IMS. AIMIL PHARMACEUTICALS (INDIA) LTD was incorporated on 30th November 1984 by our Founder & Chairman Sh. K.K. Sharma with a vision to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment and desire to serve the people to live healthily and a happy life. The company is engaged in manufacturing and marketing of Ayurvedic proprietary and classical medicines. From a very modest beginning in 1985, the company has made long strides in emerging as one of the leading companies in Ayurvedic/ Herbal Medicines and achieved a turnover of Rs. 205 Crores in the last financial year 2015-16.
CSIR (Govt. of India)
CSIR-National Botanical Research Institute, Lucknow and CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow took an initiative to develop a promising, safe, non-toxic drug regime to help effectively maintain normal blood glucose levels and reduce the chances of long term complications. The invention provides a novel synergistic herbal formulation for management of diabetes. Formulation comprises of medicinal plant extracts together with the conventional additives to the oral dosage forms, which includes the traditional plant extracts and processing.
NBRI-CIMAP SCIENTISTS EFFORTS
It has been highly commendable on the part of scientists at CSIR-NBRI and CSIR-CIMAP to have in-depth research studies to evolve scientifically the most desirable formulation that has been validated experimentally to address the disorder with a difference and that too in completely patient friendly manner. Not only that, but the product also imparts the much needed good quality life in the patients.
TECHNOLOGY TRANSFERRED TO